Impact of baseline serum lactate dehydrogenase concentration on the efficacy of pembrolizumab and ipilimumab in patients with advanced melanoma: data from KEYNOTE-006

2.50
Hdl Handle:
http://hdl.handle.net/10541/620826
Title:
Impact of baseline serum lactate dehydrogenase concentration on the efficacy of pembrolizumab and ipilimumab in patients with advanced melanoma: data from KEYNOTE-006
Authors:
Long, G; Blank, C; Ribas, A; Mortier, L; Carlino, M; Lotem, M; Lorigan, Paul C ( 0000-0002-8875-2164 ) ; Neyns, B; Petrella, T; Puzanov, I; Richtig, E; O’Day, S; Masucci, G; Lebbe, C; Steven, N; Lutzky, J; Hille, D; Ebbinghaus, S; Ibrahim, N; McNeil, C
Affiliation:
Melanoma Institute Australia, Medical Oncology, Sydney
Citation:
Impact of baseline serum lactate dehydrogenase concentration on the efficacy of pembrolizumab and ipilimumab in patients with advanced melanoma: data from KEYNOTE-006. 2017, 72:S122 Eur J Cancer
Journal:
European Journal of Cancer
Issue Date:
Feb-2017
URI:
http://hdl.handle.net/10541/620826
DOI:
10.1016/S0959-8049(17)30482-3
Additional Links:
http://linkinghub.elsevier.com/retrieve/pii/S0959804917304823
Type:
Meetings and Proceedings
Language:
en
ISSN:
09598049
Appears in Collections:
All Christie Publications

Full metadata record

DC FieldValue Language
dc.contributor.authorLong, Gen
dc.contributor.authorBlank, Cen
dc.contributor.authorRibas, Aen
dc.contributor.authorMortier, Len
dc.contributor.authorCarlino, Men
dc.contributor.authorLotem, Men
dc.contributor.authorLorigan, Paul Cen
dc.contributor.authorNeyns, Ben
dc.contributor.authorPetrella, Ten
dc.contributor.authorPuzanov, Ien
dc.contributor.authorRichtig, Een
dc.contributor.authorO’Day, Sen
dc.contributor.authorMasucci, Gen
dc.contributor.authorLebbe, Cen
dc.contributor.authorSteven, Nen
dc.contributor.authorLutzky, Jen
dc.contributor.authorHille, Den
dc.contributor.authorEbbinghaus, Sen
dc.contributor.authorIbrahim, Nen
dc.contributor.authorMcNeil, Cen
dc.date.accessioned2018-02-15T21:53:36Z-
dc.date.available2018-02-15T21:53:36Z-
dc.date.issued2017-02-
dc.identifier.citationImpact of baseline serum lactate dehydrogenase concentration on the efficacy of pembrolizumab and ipilimumab in patients with advanced melanoma: data from KEYNOTE-006. 2017, 72:S122 Eur J Canceren
dc.identifier.issn09598049-
dc.identifier.doi10.1016/S0959-8049(17)30482-3-
dc.identifier.urihttp://hdl.handle.net/10541/620826-
dc.language.isoenen
dc.relation.urlhttp://linkinghub.elsevier.com/retrieve/pii/S0959804917304823en
dc.rightsArchived with thanks to European Journal of Canceren
dc.titleImpact of baseline serum lactate dehydrogenase concentration on the efficacy of pembrolizumab and ipilimumab in patients with advanced melanoma: data from KEYNOTE-006en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentMelanoma Institute Australia, Medical Oncology, Sydneyen
dc.identifier.journalEuropean Journal of Canceren
All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.